![A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder | Journal of Child and Adolescent Psychopharmacology A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder | Journal of Child and Adolescent Psychopharmacology](https://www.liebertpub.com/cms/10.1089/cap.2021.0077/asset/images/medium/cap.2021.0077_figure4.jpg)
A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder | Journal of Child and Adolescent Psychopharmacology
![These highlights do not include all the information needed to use AZSTARYS safely and effectively. See full prescribing information for AZSTARYS. AZSTARYS (serdexmethylphenidate and dexmethylphenidate) capsules, for oral use, CII Initial U.S. These highlights do not include all the information needed to use AZSTARYS safely and effectively. See full prescribing information for AZSTARYS. AZSTARYS (serdexmethylphenidate and dexmethylphenidate) capsules, for oral use, CII Initial U.S.](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=azstarys-04.jpg&id=739439)
These highlights do not include all the information needed to use AZSTARYS safely and effectively. See full prescribing information for AZSTARYS. AZSTARYS (serdexmethylphenidate and dexmethylphenidate) capsules, for oral use, CII Initial U.S.
![Corium's Azstarys (serdexmethylphenidate and dexmethylphenidate) Receives the US FDA's Approval for ADHD in Patients Aged 6 Years and Older Corium's Azstarys (serdexmethylphenidate and dexmethylphenidate) Receives the US FDA's Approval for ADHD in Patients Aged 6 Years and Older](https://www.pharmashots.com/public/images/20211116014414_ogImage_50.jpg)